Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Tamargo

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Expert Review of Clinical Pharmacology|March 9, 2023
Sex and gender differences in the treatment of arterial hypertensionJuan Tamargo, Ricardo Caballero, Eva Delpón Mosquera
International Journal of Cardiology|January 10, 2016
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular preventionJuan Tamargo, José M Castellano, Valentín Fuster
Expert Opinion on Pharmacotherapy|January 22, 2014
Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diureticsJuan Tamargo, Julian Segura, Luis M Ruilope
Seminars in Nephrology|July 14, 2014
Comparison of agents that affect aldosterone actionJuan Tamargo, Anna Solini, Luis M Ruilope
Expert Opinion on Pharmacotherapy|January 25, 2014
Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agentsJuan Tamargo, Julian Segura, Luis M Ruilope
Current Opinion in Nephrology and Hypertension|July 28, 2005
New insights in the pharmacological therapy of arterial hypertensionAngel Cogolludo, Francisco Pérez-Vizcaíno, Juan Tamargo
Diabetes & Vascular Disease Research|February 14, 2016
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidenceGiuseppe Ambrosio, Juan Tamargo, Peter J Grant
International Journal of Cardiology|April 28, 2023
Herbal medicines for the treatment of cardiovascular diseases: Benefits and risks - A narrative reviewLucinda Villaescusa, Cristina Zaragozá, Francisco Zaragozá, et al.
Discovery Medicine|December 1, 2011
New therapeutic targets for the development of positive inotropic agentsJuan Tamargo, Juan Duarte, Ricardo Caballero, et al.
Expert Opinion on Investigational Drugs|April 2, 2009
I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillationJuan Tamargo, Ricardo Caballero, Ricardo Gómez, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Expert Review of Clinical Pharmacology|March 9, 2023
Sex and gender differences in the treatment of arterial hypertensionJuan Tamargo, Ricardo Caballero, Eva Delpón Mosquera
International Journal of Cardiology|January 10, 2016
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular preventionJuan Tamargo, José M Castellano, Valentín Fuster
Expert Opinion on Pharmacotherapy|January 22, 2014
Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diureticsJuan Tamargo, Julian Segura, Luis M Ruilope
Seminars in Nephrology|July 14, 2014
Comparison of agents that affect aldosterone actionJuan Tamargo, Anna Solini, Luis M Ruilope
Expert Opinion on Pharmacotherapy|January 25, 2014
Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agentsJuan Tamargo, Julian Segura, Luis M Ruilope
Current Opinion in Nephrology and Hypertension|July 28, 2005
New insights in the pharmacological therapy of arterial hypertensionAngel Cogolludo, Francisco Pérez-Vizcaíno, Juan Tamargo
Diabetes & Vascular Disease Research|February 14, 2016
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidenceGiuseppe Ambrosio, Juan Tamargo, Peter J Grant
International Journal of Cardiology|April 28, 2023
Herbal medicines for the treatment of cardiovascular diseases: Benefits and risks - A narrative reviewLucinda Villaescusa, Cristina Zaragozá, Francisco Zaragozá, et al.
Discovery Medicine|December 1, 2011
New therapeutic targets for the development of positive inotropic agentsJuan Tamargo, Juan Duarte, Ricardo Caballero, et al.
Expert Opinion on Investigational Drugs|April 2, 2009
I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillationJuan Tamargo, Ricardo Caballero, Ricardo Gómez, et al.
Pageof 19